Daniel McGahn
Chief Executive Officer at AMERICAN SUPERCONDUCTOR CORPORATION
Net worth: 15 M $ as of 2024-03-30
Profile
Daniel Patrick McGahn is currently the Chairman, President & Chief Executive Officer at American Superconductor Corp.
He previously served as a Director at BioDE Ventures Ltd.
and as an Independent Director at Exro Technologies, Inc. from 2017 to 2021.
McGahn also held the position of Chief Marketing Officer & Executive Vice President at Konarka Technologies, Inc. from 2003 to 2006.
Additionally, he served as the Chief Operating Officer & General Manager at Hyperion Catalysis International, Inc. McGahn obtained his undergraduate and graduate degrees from the Massachusetts Institute of Technology.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-06-21 | 1,088,672 ( 3.01% ) | 15 M $ | 2024-03-30 |
Daniel McGahn active positions
Companies | Position | Start |
---|---|---|
AMERICAN SUPERCONDUCTOR CORPORATION | Chief Executive Officer | 2011-06-15 |
Former positions of Daniel McGahn
Companies | Position | End |
---|---|---|
EXRO TECHNOLOGIES INC. | Director/Board Member | 2021-08-18 |
Konarka Technologies, Inc.
Konarka Technologies, Inc. SemiconductorsElectronic Technology Konarka Technologies, Inc. developed nano-enabled polymer photovoltaic materials. The company was founded in 2001 and was headquartered in Lowell, MA. | Sales & Marketing | 2005-12-31 |
BioDE Ventures Ltd.
BioDE Ventures Ltd. BiotechnologyHealth Technology BioDE Ventures Ltd. develops biotechnology and pharmaceutical products. Its primary product is the omiganan gel, which has completed Phase III studies, a cationic peptide for the treatment of rosacea and dermatological diseases. The company is headquartered in Vancouver, Canada. | Director/Board Member | - |
Hyperion Catalysis International, Inc.
Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Chief Operating Officer | - |
Training of Daniel McGahn
Massachusetts Institute of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AMERICAN SUPERCONDUCTOR CORPORATION | Producer Manufacturing |
EXRO TECHNOLOGIES INC. | Producer Manufacturing |
Private companies | 3 |
---|---|
Konarka Technologies, Inc.
Konarka Technologies, Inc. SemiconductorsElectronic Technology Konarka Technologies, Inc. developed nano-enabled polymer photovoltaic materials. The company was founded in 2001 and was headquartered in Lowell, MA. | Electronic Technology |
Hyperion Catalysis International, Inc.
Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Producer Manufacturing |
BioDE Ventures Ltd.
BioDE Ventures Ltd. BiotechnologyHealth Technology BioDE Ventures Ltd. develops biotechnology and pharmaceutical products. Its primary product is the omiganan gel, which has completed Phase III studies, a cationic peptide for the treatment of rosacea and dermatological diseases. The company is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Daniel McGahn